¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ ½ÃÀå : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø(2024-2032³â)
Nanorobots In Healthcare Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1536714
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 322 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,475,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,403,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,781,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ ½ÃÀå ±Ô¸ð´Â 2023³â 68¾ï 9,032¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 6.20%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ ½ÃÀå - ½ÃÀå ¿ªÇÐ

³ª³ë±â¼úÀÇ ¹ßÀüÀ¸·Î ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ³ª³ë·Îº¿ÀÇ Çʿ伺ÀÌ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù.

³ª³ë·Îº¿Àº °³ÀÎÀÇ À¯ÀüÀÚ ±¸¼º¿¡ µû¶ó ƯÁ¤ ¾à¹°À» ¿î¹ÝÇϵµ·Ï ¼³°èÇÒ ¼ö ÀÖ¾î ¾Ï, ´ç´¢º´, ½ÉÇ÷°ü Áúȯ µîÀÇ Ä¡·á È¿°ú¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ³ª³ë·Îº¿Àº ¾à¹°À» º´µç ¼¼Æ÷¿¡ Á÷Á¢ Àü´ÞÇÒ ¼ö Àֱ⠶§¹®¿¡ ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈ­Çϰí Ä¡·á È¿°ú¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. À̴ ƯÈ÷ ¾Ï Ä¡·á¿¡ À¯¿ëÇϸç, Ç¥ÀûÈ­µÈ Àü´ÞÀ» ÅëÇØ °Ç°­ÇÑ Á¶Á÷¿¡ ´ëÇÑ ¼Õ»óÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ³ª³ë·Îº¿Àº ¼ºÀåÀÎÀÚ³ª Áٱ⼼Æ÷¸¦ ƯÁ¤ ºÎÀ§¿¡ Àü´ÞÇÏ¿© ¼Õ»óµÈ Á¶Á÷ÀÇ È¸º¹°ú Àç»ýÀ» µ½°í, ô¼ö ¼Õ»óÀ̳ª ½ÉÀ庴°ú °°Àº Áúº´À» Ä¡·áÇÒ ¼ö ÀÖÀ¸¸ç, 2025³â±îÁö ¼¼°è ³ª³ë±â¼ú ½ÃÀå ±Ô¸ð´Â 3,061¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀüÀÚ, »ý¹°ÀÇÇÐ, ¿¡³ÊÁö ºÐ¾ß¿¡¼­ÀÇ ÀÀ¿ëÀÌ ¼¼°è ³ª³ë±â¼ú ½ÃÀå Á¡À¯À²ÀÇ 70%¸¦ Â÷ÁöÇϰí ÀÖÀ¸¸ç, 2019³â FDA´Â 55°ÇÀÇ ³ª³ë¹°ÁúÀÌ Æ÷ÇÔµÈ ÀǾàǰ ½ÅûÀ» Á¢¼öÇß½À´Ï´Ù.

ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¸Å³â ¾à 6.20%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯Çüº° ¼¼ºÐÈ­¿¡ µû¸£¸é, ¹ÙÀÌ¿À³ª³ë·Îº¿ÀÌ 2023³â¿¡ °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» º¸¿´½À´Ï´Ù.

¿ëµµº°·Î´Â ¾à¹° Àü´ÞÀÌ 2023³â ÁÖ¿ä À¯ÇüÀ¸·Î ²ÅÇû½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ÁÖ¿ä ¼öÀÍ¿øÀ̾ú½À´Ï´Ù.

ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ ¼¼°è ½ÃÀåÀº À¯Çü, ÀÀ¿ë ºÐ¾ß, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº ¿ëµµ¿¡ µû¶ó ¾à¹° Àü´Þ, ¼ö¼ú, Áø´Ü ¹× ¿µ»ó Áø´Ü, À¯ÀüÀÚ Ä¡·áÀÇ 4°¡Áö ¹üÁÖ·Î ³ª´µ¸ç, 2023³â °¡Àå ³ôÀº ¸ÅÃâ Á¡À¯À²À» º¸ÀÌ´Â ºÎ¹®Àº Ç¥Àû ¾à¹° Àü´ÞÀÔ´Ï´Ù. ³ª³ë·Îº¿Àº ¿ÜºÎ ÀÚ±ØÀ̳ª ³»ºÎ ¿¡³ÊÁö ¿øÀÇ ±â°èÀû ÈûÀ» ÀÚÀ²ÀûÀÎ ¿òÁ÷ÀÓÀ¸·Î º¯È¯ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» °¡Áø ÃʼÒÇü Áö°¢ ±â°èÀÔ´Ï´Ù. ´Ù¾çÇÑ ÃßÁø ¸ÞÄ¿´ÏÁòÀ» ÀÌ¿ëÇÏ¿© ÀÎü ³»¿¡¼­ ÀÚÀ²ÀûÀ¸·Î À̵¿ÇÏ°í ±âÁ¸ Àü´Þ Àü·«À¸·Î´Â Á¢±ÙÇϱ⠾î·Á¿î º´º¯¿¡ µµ´ÞÇÒ ¼ö Àֱ⠶§¹®¿¡ ³ª³ë·Îº¿Àº Ç¥Àû ¾à¹° Àü´Þ¿¡ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ³ª³ë·Îº¿Àº »ýüÀûÇÕ¼º ³»Àμº ¿¬·á·Î ÀÛµ¿Çϱ⠶§¹®¿¡ ÀÌ·¯ÇÑ ±â¼ú Áß È­ÇÐÀû/»ýÈ­ÇÐÀû ÃßÁø ³ª³ë·Îº¿Àº in vivo¿¡¼­ ¼ÒÈ­°ü(GI) ¿°Áõ Ä¡·á¿¡ Å« ±â´ë¸¦ ¸ðÀ¸°í ÀÖ½À´Ï´Ù.

½ÃÀåÀº À¯Çü¿¡ µû¶ó ¹ÙÀÌ¿À ³ª³ë·Îº¿, ÀÚ±â À¯µµ ³ª³ë·Îº¿, È­ÇÐ ³ª³ë·Îº¿, ±¤ÇÐ Á¦¾î ³ª³ë·Îº¿ÀÇ ³× °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ¹ÙÀÌ¿À³ª³ë·Îº¿ ºÐ¾ß´Â ÀÌ ºÐ¾ßÀÇ ¿¬±¸°³¹ß(R&D) Ȱµ¿ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 12¿ù Áß±¹ ´×º¸¿Í ´º¿å ´ëÇÐ ¿¬±¸ÁøÀº DNA¸¦ ÀÌ¿ëÇÑ ¼ÒÇü ·Îº¿À» °³¹ßÇß½À´Ï´Ù. ÀÌ 3D DNA ³ª³ë·Îº¿Àº ÀÚ°¡ º¹Á¦Çϰí ȯÀÚÀÇ Ç÷·ù¸¦ Ž»öÇÏ¿© ¾Ï¼¼Æ÷¸¦ ã¾Æ³»¾î ħ½ÀÀû ½Ã¼úÀ» ÇÇÇϰí Á¤È®ÇÑ ¾à¹° Àü´Þ¿¡ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ ½ÃÀå - Áö¸®Àû ÅëÂû·Â

»ý¹° ÀÇÇÐ ¿¬±¸, ±â¼ú Çõ½Å, °­·ÂÇÑ ¿¬±¸ ÀÎÇÁ¶ó¿¡ ´ëÇÑ ¸¹Àº ÅõÀÚ·Î ÀÎÇØ ºÏ¹Ì´Â 2023³â ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ÀÇ ¼¼°è ¸ÅÃâ Á¡À¯À² 40.6%¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ºÏ¹ÌÀÇ ³ôÀº ÀÇ·áºñ ¼öÁذú ½ÃÀå ÁøÃâÀÌ È°¹ßÇÑ ±â¾÷µéÀº ³ª³ë·Îº¿À» Æ÷ÇÔÇÑ Ã·´Ü ÀÇ·á ±â¼ú µµÀÔ¿¡ À¯¸®ÇÑ È¯°æÀ» Á¶¼ºÇϰí ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ij³ª´ÙÀÇ ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿Àº °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºêÀÇ Ã¤Åà Ȯ´ë°¡ ½ÃÀå È®´ëÀÇ ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù.

ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ ½ÃÀå - °æÀï ±¸µµ :

ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â Zymergen Inc., Xidex Corp., Synthace Limited, Thermo Fisher Scientific Inc. Zymergen Inc.´Â ´Ù¾çÇÑ ÇコÄɾî¿ë ³ª³ë·Îº¿ °³¹ß µî ¹ÙÀÌ¿ÀÆÑ󸵿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, Ginkgo Bioworks´Â ÇÕ¼º»ý¹°ÇÐ ºÐ¾ß·Î À¯¸íÇϸç, Áø´Ü ¹× Ä¡·á¿ë ³ª³ë·Îº¿À» °³¹ßÇϱâ À§ÇØ Ç÷§ÆûÀ» Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. Imina Technologies SA´Â ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ °³¹ß ¹× Å×½ºÆ®¿¡ ÇʼöÀûÀÎ ³ª³ë Á¶ÀÛ ½Ã½ºÅÛÀ» Àü¹®À¸·Î Çϰí ÀÖ½À´Ï´Ù. Àü¹® Áö½ÄÀ» Ȱ¿ëÇÏ°í ¿¬±¸°³¹ßÀ» °¡¼ÓÈ­Çϱâ À§ÇØ ±â¾÷µéÀº ÇÐ°è ¹× ¿¬±¸±â°ü°úÀÇ Çù·ÂÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ ±â°üÀº ÀÇ·á ºÐ¾ß¿¡¼­ ³ª³ë·Îº¿ÀÇ ½ÂÀÎ ¹× »ç¿ë¿¡ ´ëÇÑ ÇÁ·¹ÀÓ¿öÅ©¸¦ ¼ö¸³Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå °³Ã´¿¡ Áß¿äÇÑ ¿ä¼Ò·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±â¾÷µéÀº ±â¼ú Çõ½Å¿¡ ÁýÁßÇÏ°í Æ¯Ç㸦 ÃëµæÇÏ¿© ±â¼úÀ» º¸È£ÇÏ°í °æÀï ¿ìÀ§¸¦ È®º¸Çϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÇコÄÉ¾î ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ ½ÃÀå ÁÖ¿ä µ¿Çâ

Á¦4Àå ÇコÄÉ¾î »ê¾÷ ³ª³ë·Îº¿ Á¶»ç

Á¦5Àå ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ÇコÄÉ¾î ½ÃÀå ±¸µµ

Á¦7Àå ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ ½ÃÀå : À¯Çüº°

Á¦8Àå ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ ½ÃÀå : ¿ëµµº°

Á¦9Àå ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ÇコÄÉ¾î ºÐ¾ß ³ª³ë·Îº¿ ½ÃÀå : Áö¿ª

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ÇコÄÉ¾î ¾÷°è ³ª³ë·Îº¿

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Nanorobots In Healthcare Market size was valued at USD 6,890.32 Million in 2023, expanding at a CAGR of 6.20% from 2024 to 2032.

Nanorobots in healthcare refer to extremely small robotic devices, typically ranging in size from 1 to 100 nanometers, designed to perform specific tasks at a microscopic level within the human body. These nanorobots hold promise for revolutionizing medical diagnostics, treatment, and surgery due to their ability to interact with biological systems at a molecular or cellular level. The use of nanorobots in healthcare raises regulatory and ethical questions that need to be addressed to ensure patient safety and public acceptance. Developing methods to precisely control and navigate nanorobots within the complex environment of the human body is a significant challenge. Advances in nanotechnology, materials science, and molecular biology are driving innovations in nanorobot design and functionality. Nanorobots in healthcare represent a cutting-edge frontier in medical technology, offering the potential for highly targeted and efficient treatments.

Nanorobots In Healthcare Market- Market Dynamics

Advancements in Nanotechnology Driving the Need For Nanorobots In Healthcare

Nanorobots can be designed to carry specific drugs tailored to an individual's genetic makeup, enhancing the effectiveness of treatments for conditions like cancer, diabetes, and cardiovascular diseases. Nanorobots can deliver drugs directly to diseased cells, minimizing side effects and increasing the efficacy of treatments. This is particularly beneficial in cancer therapy, where targeted delivery can reduce damage to healthy tissues. Nanorobots can aid in the repair and regeneration of damaged tissues by delivering growth factors or stem cells to specific sites, potentially treating conditions like spinal cord injuries and heart diseases. By 2025, the global nanotechnology market is expected to be valued at $306.1 billion. A water molecule is around 1.5 nanometres in size. Applications in electronics, biomedicine, and energy account for 70% of the global nanotechnology market share. In 2019, the FDA received 55 submissions for drug products containing nanomaterials.

Nanorobots In Healthcare Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.20% over the forecast period (2024-2032)

Based on type segmentation, Bio-Nanorobots was predicted to show maximum market share in the year 2023

Based on application segmentation, Drug Delivery was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Nanorobots In Healthcare Market- Segmentation Analysis:

The Global Nanorobots In Healthcare Market is segmented on the basis of Type, Application, End User, and Region.

The market is divided into four categories based on application: Drug Delivery, Surgery, Diagnosis and Imaging, and Gene Therapy. In 2023, the segment with the highest revenue share was targeted medicine delivery. Nanorobots are minuscule, sentient machines that possess the ability to transform mechanical force from external stimuli or internal energy sources into autonomous motion. Because they can autonomously traverse through the human body utilizing various propulsion mechanisms to reach sick areas that are difficult to access with existing delivery strategies, nanorobots are largely employed for targeted medicine delivery. Because they run on biocompatible endogenous fuels, chemically/biochemically propelled nanorobots among these technologies have a lot of promise for use in the in vivo treatment of gastrointestinal (GI) inflammation.

The market is divided into four categories based on type: Bio-Nanorobots, Magnetically Guided Nanorobots, Chemical-Nanorobots, and Optically Controlled Nanorobots. The bio-nanorobotics segment is expected to grow at the fastest rate during the forecast period due to an increase in research and development (R&D) activities in the field. For example, in December 2023, researchers at universities in Ningbo, China, and New York developed small robots using DNA. These 3D DNA nanorobots could replicate themselves and be used for precise drug delivery by navigating through a patient's bloodstream to locate cancer cells, thereby avoiding invasive procedures. Such a

Nanorobots In Healthcare Market- Geographical Insights

Due in significant part to its high investment in biomedical research, technological innovation, and robust research infrastructure, North America accounted for 40.6% of the global nanorobot revenue share in the healthcare market in 2023. Moreover, the high level of healthcare spending in North America combined with the existence of well-established market participants fosters a climate that is favourable to the adoption of cutting-edge medical technologies, including nanorobots. During the projected period, Canada's nanorobots in the healthcare sector are expected to increase at the fastest rate. Growing strategic initiative adoption is one of the main drivers of market expansion.

Nanorobots In Healthcare Market- Competitive Landscape:

Major players in the Nanorobots In Healthcare Market include Zymergen Inc., Xidex Corp., Synthace Limited, Thermo Fisher Scientific Inc., Oxford Instruments Plc, Ginkgo Bioworks, etc. Zymergen Inc. focuses on biofacturing, including developing nanorobots for various healthcare applications. Ginkgo Bioworks is known for its work in synthetic biology, Ginkgo Bioworks leverages its platform for developing nanorobots for diagnostics and therapeutics. Imina Technologies SA specializes in nanomanipulation systems, which are crucial for developing and testing nanorobots in healthcare. Companies are increasingly collaborating with academic institutions and research organizations to leverage expertise and accelerate development. Regulatory bodies are developing frameworks for the approval and use of nanorobots in healthcare, which is a critical factor for market growth. Companies are focusing on innovation and securing patents to protect their technologies and gain a competitive edge.

Recent Developments:

In June 2023, BLADDEBOTS a project led by IBEC researcher Samuel Sanchez, focused on developing nanorobots to treat bladder cancer. To transmit BLADDEBOTS research to society, the researcher has collaborated with the Nanoinventum dissemination initiative, which brings nanotechnology to primary classrooms.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOROBOTS IN HEALTHCARE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Zymergen Inc.

Xidex Corp.

Synthace Limited

Thermo Fisher Scientific Inc.

Oxford Instruments Plc

Ginkgo Bioworks

Bruker Corporation

EV Group (EVG)

Park Systems

Imina Technologies SA

Others

GLOBAL NANOROBOTS IN HEALTHCARE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL NANOROBOTS IN HEALTHCARE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL NANOROBOTS IN HEALTHCARE MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

GLOBAL NANOROBOTS IN HEALTHCARE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Nanorobots In Healthcare Market Overview

2. Executive Summary

3. Nanorobots In Healthcare Key Market Trends

4. Nanorobots In Healthcare Industry Study

5. Nanorobots In Healthcare Market: COVID-19 Impact Analysis

6. Nanorobots In Healthcare Market Landscape

7. Nanorobots In Healthcare Market - By Type

8. Nanorobots In Healthcare Market - By Application

9. Nanorobots In Healthcare Market - By End User

10. Nanorobots In Healthcare Market- By Geography

11. Key Vendor Analysis- Nanorobots In Healthcare Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â